Corebridge Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,182
| Closed | -$652K | – | 2255 |
|
|
2025
Q1 | $652K | Sell |
123,182
-523
| -0.4% | -$2.77K | ﹤0.01% | 1455 |
|
|
2024
Q4 | $836K | Sell |
123,705
-3,789
| -3% | -$25.6K | ﹤0.01% | 1407 |
|
|
2024
Q3 | $840K | Buy |
127,494
+16,284
| +15% | +$107K | ﹤0.01% | 1446 |
|
|
2024
Q2 | $834K | Buy |
+111,210
| New | +$834K | ﹤0.01% | 1430 |
|